The Hidden Eating Disorder Affecting Celiac Patients

New research shows ARFID, a restrictive eating disorder, is surprisingly common in both children and adults with celiac disease and gluten sensitivity.

Parent and child reviewing food options together, representing the challenges of restrictive eating patterns in celiac disease

Nearly one in three people with celiac disease shows signs of a restrictive eating disorder that has nothing to do with body image. New research from PubMed reveals that avoidant/restrictive food intake disorder (ARFID) appears far more frequently in celiac patients than anyone expected—affecting children and adults alike.

The study, published in Nutrients by researchers at Massachusetts General Hospital and Harvard Medical School, examined 386 patients referred to a specialized celiac center. What they found challenges the assumption that following a gluten-free diet is purely a medical necessity without psychological consequences.

What This Means for You

ARFID is different from anorexia or bulimia. People with ARFID severely limit what they eat, but not because they worry about weight or appearance. Instead, they avoid foods because of fear—fear of getting sick, fear of unfamiliar textures, or fear that something might contain gluten.

For celiac families, this distinction matters enormously. When a child refuses to eat anything except plain rice and chicken, or when an adult skips meals entirely at social events, we often assume it’s just careful gluten avoidance. This research suggests something more complex may be happening.

The Massachusetts General team found that patients with celiac disease and non-celiac gluten sensitivity showed significantly elevated ARFID symptoms compared to the general population. The restriction patterns weren’t about vanity—they were about anxiety and fear tied directly to food safety and past experiences of getting sick.

As the parent of a child with celiac disease, I recognize these patterns immediately. The hyper-vigilance that keeps my son safe can also make every meal a negotiation. Reading labels obsessively, questioning restaurant staff repeatedly, avoiding birthday parties where the food seems risky—these are survival strategies. But when does necessary caution tip into disordered eating?

Key Takeaways

  • ARFID is a restrictive eating disorder driven by fear or sensory aversion, not body image concerns.
  • The study found elevated ARFID symptoms in both pediatric and adult celiac patients.
  • This pattern appears in people with diagnosed celiac disease and those with non-celiac gluten sensitivity.
  • The restrictive behaviors stem from anxiety about food safety and fear of symptom recurrence.
  • Healthcare providers may be missing this diagnosis in celiac patients who appear to be “just following the diet carefully.”

The Science

Want to understand how this actually works? We’ll walk you through the technical details below and define every term. No medical degree required.

Understanding ARFID

Avoidant/restrictive food intake disorder is a feeding and eating disorder characterized by persistent failure to meet nutritional needs, but unlike anorexia nervosa or bulimia nervosa, it’s not motivated by concerns about body weight or shape. Instead, ARFID typically involves one or more of three patterns: avoiding foods based on sensory characteristics (texture, smell, appearance), restricting intake due to fear of aversive consequences like choking or vomiting, or showing lack of interest in eating.

The disorder was officially recognized in the DSM-5 (the standard psychiatric diagnostic manual) in 2013, making it a relatively new diagnostic category. Before that, these patterns were often dismissed as “picky eating” in children or attributed to other anxiety disorders in adults.

The Study Design

The research team at Massachusetts General Hospital reviewed 386 consecutive patient referrals to their tertiary celiac center between June 2019 and June 2022. The patient population ranged from 2 to 82 years old, with 68% female participants.

Eligible patients either had histologically confirmed celiac disease—meaning intestinal damage verified through biopsy—or met clinical criteria for non-celiac gluten sensitivity (NCGS), which involves gluten-related symptoms without the characteristic intestinal damage or positive antibody markers of celiac disease.

The researchers used validated screening tools to assess ARFID symptoms longitudinally, tracking patients over time rather than capturing just a single snapshot. This approach allowed them to observe whether restrictive eating patterns persisted, worsened, or improved as patients adjusted to gluten-free living.

Why This Happens

The connection between celiac disease and ARFID makes intuitive sense when you consider the lived experience of diagnosis and dietary management. For many celiac patients, eating is no longer a simple pleasure—it becomes a risk-benefit calculation performed dozens of times daily.

Gluten exposure causes real, sometimes severe symptoms: abdominal pain, vomiting, diarrhea, fatigue, brain fog. After experiencing these symptoms repeatedly, the brain learns to associate certain foods, eating situations, or even food textures with danger. This is classical fear conditioning—the same mechanism behind phobias.

In children, this can manifest as extreme selectivity that goes beyond avoiding obvious gluten sources. A child who once got sick from contaminated french fries might refuse all fried foods. One who experienced symptoms after a birthday party might develop anxiety around any food prepared by others.

In adults, the patterns often look like social withdrawal and progressive dietary narrowing. Skipping work lunches, declining dinner invitations, eating the same “safe” meals repetitively—these behaviors protect against gluten exposure but also isolate people and limit nutritional variety.

Distinguishing Necessary Caution from Disorder

Here’s where clinical judgment becomes crucial. The gluten-free diet for celiac disease requires genuine vigilance. Reading every ingredient label, asking detailed questions about food preparation, and avoiding situations with high cross-contact risk are medically necessary behaviors, not disordered ones.

ARFID emerges when the restriction extends beyond medical necessity and begins causing harm—nutritional deficiencies, significant weight loss, impaired social functioning, or severe anxiety that interferes with daily life. For example, refusing to eat anything not prepared personally in a home kitchen might be ARFID territory. So is limiting intake to only three or four “safe” foods despite having access to many gluten-free options.

The Massachusetts General team noted that many celiac patients with ARFID symptoms had never been screened for the disorder. Their restrictive eating was assumed to be appropriate disease management rather than a co-occurring mental health condition requiring its own treatment.

Connection to Prior Research

This finding fits into a broader pattern researchers have been documenting about the psychological impact of celiac disease. Earlier this year we covered body image perception and emotional awareness in adults with celiac disease, which found that celiac patients showed altered body image perception even when ARFID-style restriction wasn’t present.

The psychological burden extends to caregivers as well. A recent cross-sectional study we discussed examined the psychosocial impact on primary caregivers of children with celiac disease, documenting elevated stress, anxiety, and social isolation among parents—factors that can inadvertently contribute to a child’s food anxiety.

These studies collectively paint a picture of celiac disease as a condition with profound mental health dimensions that extend well beyond the physical symptoms of gluten exposure.

What Needs to Change

The ARFID findings should prompt immediate changes in how gastroenterologists and dietitians approach celiac care. Routine screening for eating disorder symptoms should become standard practice at celiac centers, especially for pediatric patients and newly diagnosed adults still adjusting to dietary restrictions.

Treatment for ARFID in celiac patients requires specialized expertise—providers who understand both the legitimate medical necessity of gluten avoidance and the psychological mechanisms driving excessive restriction. Exposure therapy, a common ARFID treatment that involves gradually introducing feared foods, must be adapted for celiac patients since some food fears are medically justified.

The goal isn’t to make celiac patients less cautious about gluten. It’s to help them distinguish between genuine risk and anxiety-driven avoidance, expand their diet within gluten-free boundaries, and develop a healthier relationship with food and eating.

Moving Forward

For celiac families, this research validates what many of us have sensed intuitively—that the psychological toll of dietary management can be as challenging as the physical disease itself. If your child refuses most gluten-free foods despite having access to safe options, or if you find yourself skipping meals entirely rather than navigating uncertain food situations, consider discussing ARFID screening with your healthcare team.

The Massachusetts General study opens the door for better recognition and treatment of this co-occurring condition. As awareness grows, we can hope for more integrated care models that address both the immunological and psychological dimensions of living gluten-free.

References

Atkins, M., Peterson, B., Staller, K., Kuo, B., Michael, B., Savage, M., Leonard, M. M., & Burton-Murray, H. (2026). Avoidant/Restrictive Food Intake Disorder Is Common in Adult and Pediatric Patients with Celiac Disease and Non-Celiac Gluten Sensitivity. Nutrients, 18(10), 1585. https://doi.org/10.3390/nu18101585

Medical Disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your gastroenterologist or healthcare provider about your specific condition. Celiac disease management should be guided by your medical team.